SME Spotlight - Unum Therapeutics
February 28, 2018
Unum Therapeutics is a Cambridge, MA-based clinical-stage biopharmaceutical company focused on the development of novel immunotherapy products based on its universal Antibody-Coupled T-cell Receptor (ACTR). ACTR therapies are designed to harness the power of a patient’s immune system to cure cancer. When combined with an antibody that recognizes a target on the surface of tumor cells, the ACTR receptor can direct an individual’s T-cells to kill the tumor. Unlike other approaches (such as CAR-T or TCR), in which a cell’s receptor is trained to treat a narrow set of tumors, our therapy is not restricted to a particular target and may be used in many different cancer types.